A novel library screen identifies immunosuppressors that promote osteoblast differentiation

► High-throughput screen identifies osteogenic compounds. ► Two immunosuppressors among many selected for secondary analysis. ► Rapamycin and FK-506 promote osteogenesis. ► Pathway analysis supports different roles. ► Novel approach for identifying potential factors mitigating bone loss.